Haematex Research in Hornsby, New South Wales | Medical and health

Haematex Research

Locality: Hornsby, New South Wales

Phone: +61 2 9482 2288

Address: 9/17 King Rd 2077 Hornsby, NSW, Australia

Website: http://www.haematex.com/

Likes: 13

Add/Update information

Reviews

Tags

• Medical and health
• Medical research centre
• Biotechnology company
• Scientist

18.01.2022 Heparin Resistant Recalcifying Solution (HRRS) takes the guesswork out of prolonged clotting time tests that may be contaminated with the presence of heparin. This is a new and unique product that is faster, cheaper and more effective than existing methods of heparin neutralization. It can replace the usual M/40 calcium chloride solution in APTT and KCT tests to immediately and rapidly eliminate the effects of unfractionated heparin in concentrations up to 1 u/ml in normal plasma. See our website for more details or contact us at Haematex.

17.01.2022 Our latest newsletter can be found here:

10.01.2022 WOW - a WORLD of support for #WorldThrombosis Day! Please join us in welcoming new #WTDay15 Partners from Italy, Mexico, Australia, Ireland, United Kingdom, Br...azil, Namibia, Pakistan and Austria. Click like to show your support! - Ospedale Papa Giovanni XXIII, Italy - Clinica de Atencion Preventiva del Viajero UNAM, Mexico - Canterbury Hospital, Australia - Haematex Research, Australia - Mater Misericordiae University Hospital, Ireland - Hart Biologicals Ltd., United Kingdom - Hospital Meridional, Brazil - James Paget University Hospital NHS Foundation Trust, United Kingdom - Karachi Medical Centre, Pakistan - Medical University of Vienna, Austria - Namibia Institute of Pathology, Namibia Thank you to ALL partner organizations who are finalizing their awareness-building plans around the world! We are humbled by your support and dedication to saving lives! Help save the 1! www.worldthrombosisday.org

09.01.2022 Bioporto have recently released a new antibody, the Anti-Tau protein, and they have unveiled their latest product, the gRAD lateral flow device. The generic Rapid Assay Device (gRAD) makes it easier and faster to develop your own customized qualitative or semi quantitative* lateral flow assay. For more information on either of these products visit www.bioporto.com

07.01.2022 Here is a fantastic animation showing the impacts of Acute Kidney Injury and the influence that the biomarker NGAL could have on reducing the time in which AKI is detected.